Research map: Bispecific Antibodies Are Associated With Progressive Multifocal Leukoencephalopathy

Back to the article

Papers in this map

  1. Teclistamab in Relapsed or Refractory Multiple Myeloma · Philippe Moreau · 2022 · 1248 citations · Cited by this paper
  2. Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments · Philippe‐Antoine Bilodeau · 2026 · 8 citations · Related
  3. Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma · Ajai Chari · 2022 · 725 citations · Cited by this paper
  4. miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis · 2026 · Related
  5. PML diagnostic criteria · Joseph R. Berger · 2013 · 704 citations · Cited by this paper
  6. Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder · 2026 · Related
  7. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease · Irene C. M. Cortese · 2020 · 391 citations · Cited by this paper
  8. Fulminant Amyloid β–Related Angiitis With Herniation and Rapid Response to Tocilizumab · 2026 · Related
  9. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy · Irene C. M. Cortese · 2019 · 371 citations · Cited by this paper
  10. Double-Negative Neuromyelitis Optica Spectrum Disorder · 2026 · Related
  11. Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study · Saad Z. Usmani · 2021 · 333 citations · Cited by this paper
  12. Vestibular and Ocular Motor Phenotype in a Case of Paraneoplastic Autoimmune Kelch-Like Protein-11 Encephalitis · 2026 · Related
  13. T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals · Nora Philipp · 2022 · 283 citations · Cited by this paper
  14. Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis · 2026 · Related
  15. Allogeneic BK Virus–Specific T Cells for Progressive Multifocal Leukoencephalopathy · Muharrem Müftüoğlu · 2018 · 175 citations · Cited by this paper
  16. Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis · 2026 · Related
  17. Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis · Gemma K. Reynolds · 2023 · 124 citations · Cited by this paper
  18. HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children · 2026 · Related
  19. Prognostic Value of JC Virus Load in Cerebrospinal Fluid of Patients with Progressive Multifocal Leukoencephalopathy · Yassine Taoufik · 1998 · 116 citations · Cited by this paper
  20. Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder · 2026 · Related
  21. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy · Constantin Theodore Yiannoutsos · 1999 · 110 citations · Cited by this paper
  22. JC Virus Load in Progressive Multifocal Leukoencephalopathy: Analysis of the Correlation between the Viral Burden in Cerebrospinal Fluid, Patient Survival, and the Volume of Neurological Lesions · Darı́o Garcı́a de Viedma · 2002 · 69 citations · Cited by this paper
  23. Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma · Meera Mohan · 2021 · 65 citations · Cited by this paper
  24. Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy · David J. Mock · 1999 · 50 citations · Cited by this paper
  25. Infectious complications of bispecific antibody therapy in patients with multiple myeloma · Beatrice Sim · 2023 · 49 citations · Cited by this paper
  26. Infections and Severe Hypogammaglobulinemia in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies · Guido Lancman · 2022 · 47 citations · Cited by this paper
  27. Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review · Elizabeth C. Neil · 2017 · 45 citations · Cited by this paper
  28. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy · Serena Delbue · 2012 · 40 citations · Cited by this paper
  29. Directly Isolated Allogeneic Virus–Specific T Cells in Progressive Multifocal Leukoencephalopathy · Nora Möhn · 2024 · 34 citations · Cited by this paper
  30. Human herpesvirus 6-meningoencephalitis in an HIV patient with progressive multifocal leukoencephalopathy · Masumi Ito · 2000 · 31 citations · Cited by this paper
  31. Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis · Lorenzo Vittorio Rindi · 2024 · 27 citations · Cited by this paper
  32. Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma · Masanori Daibata · 2001 · 26 citations · Cited by this paper
  33. Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy · Junji Ikeda · 2017 · 23 citations · Cited by this paper
  34. Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients · Friederike C. Schulze Lammers · 2022 · 21 citations · Cited by this paper
  35. Comprehensive Review of Bispecific Antibody Constructs In Multiple Myeloma: Affinities, Dosing Strategies and Future Perspectives · Johannes Moritz Waldschmidt · 2024 · 20 citations · Cited by this paper
  36. Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy · Kazuo Nakamichi · 2013 · 12 citations · Cited by this paper
  37. Progressive multifocal leukoencephalopathy in multiple myeloma · Brian Hoeynck · 2022 · 12 citations · Cited by this paper
  38. Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient · Panos Arvanitis · 2024 · 12 citations · Cited by this paper
  39. Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system · Elise Jonasson Nielsen · 2023 · 8 citations · Cited by this paper

Source: OpenAlex (CC0)